Title

Mike Brady

Oncological Image Analysis

We develop image analysis methods for quantitative analysis of medical images, specifically for a range of applications in cancer.

Email: 
mike.brady@oncology.ox.ac.uk
Telephone: 
+44 (0)1865 617346
College: 
Keble College

Research Summary

Image analysis based on MRI, CT, PET, SPECT, ultrasound, and various forms of microscopy, is firmly established as a basis for detection and diagnosis of disease and for illustrating aspects of the fundamental science basis of cancer.  In practice, much of image analysis is qualitative in that it relies upon the judgement of experts to interpret the images.

We aim to develop precise measurements from images, enabling us to: monitor the progression of disease; measure the response to therapy; and to estimate physical aspects of tumours, such as their size and density.  Some of many examples of our work include: measuring from a mammogram the amount and distribution of dense tissue in the breasts of post-menopausal women (currently regarded as one of the main risk factors for breast cancer); identifying complete responders to neoadjuvant chemo/radiotherapy in colorectal cancer (potentially avoiding major surgery); and classifying liver textures, such as those characteristic of a range of liver diseases.

Figure 1 illustrates some of our quantitative analysis of breast density estimated from a single mammogram.  Note that the volumes of fibroglandular tissue is expressed in cm3 while the x-ray dose estimated as a result of this particular mammogram is 2.8 mGy.  Our work forms the basis of the products of VolparaSolutions, a company we founded in 2008 based on science we did in Oxford starting in 1993.

Figure 1: (Left) A mammogram; at point a, we estimate 3.6cm fat, 2.4cm of dense tissue; at point b, 5.8cm of fat; 0.2cm of dense tissue. (Right) quantitative measurement of the amount of dense tissue in the breast.

These applications rely upon, and motivate the development of, advances in image analysis techniques: image segmentation; feature extraction; deformable image registration; atlas development; and tumour modelling. Figure 2 shows the vasculature computed automatically for one slice of an MRI volume of the liver.  This is used subsequently to detect and stage liver disease.

Biography

Sir Michael Brady was appointed half-time as Professor of Oncological Imaging in the Department of Oncology, having retired from his 25-year Professorship in Information Engineering in 2010. After obtaining degrees in mathematics, he worked in computing science, artificial intelligence, and engineering.  He founded the Oxford University Robotics Group, but switched his interests to cancer image analysis in the early 1990s.  Apart from his Oxford research, Mike has founded a number of companies, including Matakina and ScreenPoint (mammographic image analysis), Mirada Medical (medical image fusion), and Perspectum Diagnostics (liver MRI).  He is a member of CRUK’s Science Committee and chairs the Multidisciplinary Expert Review Panel and the Royal Society Publications Board. He is a Fellow of the Royal Society.

Publications

SELECTED PUBLICATIONS:

Michael Brady, Ralph Highnam, Nico Karssemeijer, Assessment of breast density, Li Qiang and Robert M. Nishikawa (ed.) Computer-Aided Detection and Diagnosis in Medical Imaging, Taylor and Francis, ISBN: 978-1439871768, 2014

Faraz Janan and Sir Michael Brady, Shape Description and Matching Using Integral Invariants on Eccentricity Transformed Images, Int. J. Computer Vision, November 2014

V. Potesil, T. Kadir, Sir Michael Brady, Learning New Parts for Landmark Localization in Whole-Body CT Scans, IEEE Transactions on Medical Imaging, Volume: 33, Issue: 4, 2014

About Us
We aim to enhance clinical and basic cancer research in Oxford with the ultimate goal of increasing cancer cure rates.
Research
In Oxford, we have a great wealth of broad-ranging expertise and a powerful network of cancer researchers.
Study With Us
Our graduate and postdoctoral training programmes for both scientists and clinicians are internationally recognised.